Pangenomic Health Inc.
Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness… Read more
Pangenomic Health Inc. (LL3) - Total Liabilities
Latest total liabilities as of September 2025: €2.04 Million EUR
Based on the latest financial reports, Pangenomic Health Inc. (LL3) has total liabilities worth €2.04 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pangenomic Health Inc. - Total Liabilities Trend (2021–2024)
This chart illustrates how Pangenomic Health Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pangenomic Health Inc. Competitors by Total Liabilities
The table below lists competitors of Pangenomic Health Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Binect AG
XETRA:MA10
|
Germany | €3.31 Million |
|
SE-Education Public Company Limited
BK:SE-ED
|
Thailand | ฿1.28 Billion |
|
Evolva Holding SA
PINK:ELVAF
|
USA | $945.30K |
|
Scandium Canada Ltd
PINK:SCDCF
|
USA | $2.11 Million |
|
Plaza Wires Limited
NSE:PLAZACABLE
|
India | ₹509.00 Million |
|
CoinSmart Financial Inc
NEO:SMRT
|
Canada | CA$61.00 Million |
|
Key ASIC Bhd
KLSE:0143
|
Malaysia | RM10.37 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Pangenomic Health Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 7.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pangenomic Health Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pangenomic Health Inc. (2021–2024)
The table below shows the annual total liabilities of Pangenomic Health Inc. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €2.44 Million | +10.31% |
| 2023-12-31 | €2.22 Million | +208.11% |
| 2022-12-31 | €719.25K | +115.05% |
| 2021-12-31 | €334.45K | -- |